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The endoplasmic reticulum (ER) is the primary subcellular organelle where proteins are synthesized and folded. When the
homeostasis of the ER is disturbed, unfolded or misfolded proteins accumulate in the ER lumen, resulting in ER stress. In response
toERstress,cellsactivateasetoftightlycontrolledregulatoryprograms,knownastheunfoldedproteinresponse(UPR),torestore
the normal function of the ER. However, if ER stress is sustained and the adaptive UPR fails to eliminate unfolded/misfolded
proteins, apoptosis will occur to remove the stressed cells. In recent years, a large body of studies has shown that ER stress-induced
apoptosis is implicated in numerous human diseases, such as diabetes and neurogenerative diseases. Moreover, emerging evidence
supports a role of ER stress in retinal apoptosis and cell death in blinding disorders such as age-related macular degeneration and
diabetic retinopathy. In the present review, we summarize recent progress on ER stress and apoptosis in retinal diseases, focusing
on various proapoptotic and antiapoptotic pathways that are activated by the UPR, and discuss how these pathways contribute to
ER stress-induced apoptosis in retinal cells.
1.Introduction
Retinal cell death has been widely held as a central event that
leadstoretinalneurodegeneration,vasculardysfunction,and
eventually irreversible blindness in ocular diseases, such as
glaucoma, retinal degeneration, diabetic retinopathy, and
uveitis. Loss of retinal ganglion cells is considered to be a
direct cause of vision loss in experimental glaucoma [1], cor-
relating with elevated intraocular pressure (IOP) [2]. Injury
of retinal pigment epithelial (RPE) cells and photoreceptors
leads to photoreceptor dysfunction and retinal degeneration
[3], as seen in both inherited and acquired degenerative
retinal diseases such as Stargardt’s Disease [4], retinitis
pigmentosa[5],andage-relatedmaculardegeneration[6].In
diabetic retinopathy, high glucose and other diabetic insults,
such as oxidants, advanced glycation end products (AGEs),
and inﬂammatory cytokines, result in neural and vascular
cell death [7, 8]. In streptozotocin-induced diabetic rats,
both retinal neurons and vascular cells become apoptotic
soon after the onset of diabetes [9]. Inﬂammation-driven
neuralandvascularcelldeathisalsoahallmarkcharacteristic
of uveitis, a chronic eye disease that cause vision loss [10–
13]. Together, these ﬁndings support a pivotal role of cell
death in the pathogenesis of retinal diseases. Apoptosis,
that is, programmed cell death, is the most common form
of cell death in various cell types, including retinal cells.
Apoptosis is tightly controlled by a variety of signaling
pathways that either promote or inhibit the apoptotic
cascades. Among the most extensively studied proapoptotic
factors in retinal cells are oxidative stress, mitochondrial dys-
function, inﬂammation, ischemia, hyperglycemia, and excit-
otoxicity [14–18]. Intriguingly, recent evidence suggests that
disturbed protein homeostasis and endoplasmic reticulum
(ER) stress also contribute to apoptosis of retinal cells
[19]. Moreover, ER stress activates a large number of genes
involved in the control of cell fate, including antiapoptotic
and proapoptotic molecules such as Bax and Bcl-2 [20, 21].
Therefore, elucidating the role and mechanisms of ER stress2 Experimental Diabetes Research
in retinal cell apoptosis may provide important insight into
the pathogenesis of retinal diseases and help in developing
new drugs to protect retinal cells and to prevent vision loss.
In the present review, we discuss the potential implication of
ER stress in retinal cell apoptosis, with a primary focus on
the signaling transduction pathways that link ER stress with
apoptosis in general as well as speciﬁc for retinal cells.
2. ERStress andthe Unfolded
ProteinResponse (UPR)
The endoplasmic reticulum (ER) is the primary intracellular
organelle responsible for protein folding, maturation, and
traﬃcking [22, 23]. The ER consists of a network of folded
membranesinwhichsecretoryandmostmembraneproteins
are synthesized, posttranslationally modiﬁed, and folded
into their correct three-dimensional conformations. Only
properly folded (mature) proteins can be transported to
the Golgi apparatus for further processing. In addition, the
ER also serves as a dynamic pool of calcium, governing
the intracellular calcium homeostasis [24]. Other major
functions of the ER include lipid and steroid hormone
synthesis,carbohydratemetabolism,anddrugdetoxiﬁcation.
Importantly, compelling evidence indicates that the ER is
one of the major machinery that senses subtle environ-
mental changes and cellular stresses, coordinates signaling
pathways, and modulates cell function and cell survival.
Various physiological and pathological circumstances, such
as excessive mutant proteins, viral infection, energy or
nutrient deprivation, as well as alteration in the redox status,
can compromise the ER capacity in protein folding, resulting
in the accumulation of unfolded or misfolded proteins in the
ERlumen,orERstress.Inturn,misfoldedproteinsaggregate
toforminsolubleintracellularorextracellulardeposit,which
is toxic to the cell. It has been demonstrated that a number
of age-related diseases, such as Alzheimer’s diseases; inﬂam-
matory disorders, such as diabetes; and neurodegenerative
diseases, such as Parkinson’s disease, are associated with
the build-up of misfolded or unfolded protein aggregates
[25–28]. To eliminate the toxic protein components, cells
activate an adaptive mechanism that consists of a number
of intracellular signaling pathways, collectively known as
unfolded protein response (UPR). The UPR relieves ER
stress and restores the protein homeostasis through three
complementary strategies: (1) halt the generation of more
unfolded proteins by suppression of protein translation;
(2) induce ER-related molecular chaperones to promote
refolding of the unfolded proteins, and (3) activate the ER-
associatedproteindegradation(ERAD)systemtoremovethe
unfolded proteins.
There are three branches of UPR that are initiated by
distinct ER stress transducers located on the ER mem-
brane: PKR-like endoplasmic reticulum kinase (PERK) [29],
inositol-requiring enzyme 1 (IRE1) [30, 31], and activating
transcription factor 6 (ATF6) [22]. In nonstressed cells,
all three ER stress transducers are kept in an inactive
state through binding to the ER chaperon glucose-regulated
protein 78 (Bip), which is also known as immunoglobulin
binding protein (Bip) [32, 33]. Upon ER stress, excessive
unfolded proteins accumulate in the ER lumen, resulting in
the dissociation of GPR78 from the ER stress transducers
[34], which triggers activation of the UPR branches. In
eukaryotic cells, UPR is an adaptive cellular response to the
disturbance of normal ER functions, which attenuate the
aggregation of unfolded or misfolded proteins and promote
cell survival [35].However, during prolonged or overwhelm-
ing ER stress, UPR fails to restore the normal function of
the ER, and apoptotic cascade will be activated [36, 37]
(Figure 1). The exact mechanism underlying the switch of
the UPR from a prosurvival mechanism to a proapoptotic
response is not clear.
2.1. The IRE1/XBP1 Pathway. IRE1 was ﬁrstly identiﬁed as
an ER transmembrane protein kinase that is essential for
signaling transduction from the ER to the nucleus [38]a n d
was subsequently found to be involved in the initiation of
the UPR [39]. There are two diﬀerent IRE1 proteins in
mammalian cells, both of which participate in the ER stress
response or UPR. IRE1α is ubiquitously expressed while
IRE1β is tissue-speciﬁc [30, 40]. During ER stress, IRE1
dissociates with Bip/Bip and becomes activated. Activated
IRE1 acquires the function as endogenous ribonuclease
(RNase) and splices a 26-nucleotide intron from the mRNA
of XBP1. The splicing results in a shift in the translational
frame of the XBP1 gene, leading to the translation of a
new protein, named spliced XBP1 [31, 41]. The newly
generated spliced XBP1 is an active transcription factor,
which in turn induces diverse downstream genes, such as
ER chaperones [42] and proteins involved in ER-associated
protein degradation (ERAD) [43]. These proteins work
together to restore the ER homeostasis and promote cell
survival. Indeed, cells deﬁcient of XBP1 are susceptible to
oxidative stress- and inﬂammation-induced cell death [44,
45], suggesting that XBP1-mediated adaptive UPR is an
important mechanism that protects the cell from apoptosis
during ER stress. In addition, the IRE1/XBP1 pathway is
also essential for embryonic development. Genetic deletion
of IRE1 or XBP1 is lethal to mouse embryo due to fetal liver
hyperplasia [46, 47]. In addition, a recent study shows that
loss of IRE1 results in severe dysfunction of the placenta and
also contributes to the embryonic lethality of IRE1 KO mice
[48].
2.2. The PERK/eIF2α/ATF4 Pathway. PERK is a serine/thre-
onine protein kinase located on the ER membrane. Like
IRE1, PERK is activated by ER stress via dimerization
and autophosphorylation upon the dissociation with Bip.
Activated PERK phosphorylates its downstream target pro-
tein, eIF2α, resulting in the inhibition of global protein
translation [49]. However, some genes with upstream open
reading frames (uORFs) in its 5 untranslated region could
escape from the eIF2α-initiated translational attenuation.
A representative example is activating transcription factor
4 (ATF4)—human ATF4 gene contains multiple uORFs
in its 5UTR whereas the murine mRNA has two uORFs
[50]. These uORFs prevent the translation of ATF4 underExperimental Diabetes Research 3
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Figure 1: Signaling pathways of the UPR. Accumulation of unfolded proteins in ER lumen results in the ER stress. In response to ER
stress, Bip dissociates from ER stress transducers and binds to unfolded and misfolded proteins, resulting in the activation of ER stress
transducers- IRE1, PERK and ATF6. Upon activation, IRE1 splices the mRNA of XBP1, and produces an active transcription factor named
spliced XBP1 (XBP1-S), which upregulates ER chaperones and proteins implicated in the ER-associated protein degradation (ERAD). In
addition, IRE1 recruits TRAF2 and ASK1, resulting in JNK activation. The activation of PERK increases phosphorylation of eIF2α, leading
to a global attenuation of protein synthesis and a concomitant increase in ATF4 translation. In turn, ATF4 induces CHOP, a proapoptotic
transcription factor. After the dissociation of Bip, ATF6 translocates to Golgi apparatus, where it is activated by proteolysis. Activated ATF6
transcriptionally induces ERAD genes and upregulates CHOP expression.
normal conditions but enhance its expression when eIF2α
is phosphorylated [51, 52]. ATF4 belongs to the superfamily
of DNA-binding proteins that includes the activator protein-
1 (AP-1) family, cAMP-response element binding proteins
(CREBs), and CREB-like proteins. As a transcription factor,
ATF4 binds to the CRE site in the promoter region of target
genes, inducing a battery of stress response genes involved
in oxidative stress, amino acid synthesis, and transportation.
In addition, ATF4 is a major inducer of C/EBP homologous
protein (CHOP), which has been considered as a central
mediator of ER stress-induced apoptosis. The role of CHOP
in coordinating the apoptotic pathways will be discussed in
detail in the following chapters.
2.3. The ATF6 Pathway. Besides XBP-1 and ATF4, ATF6
has been identiﬁed as another basic leucine zipper- (bZIP-)
containing transcription factor induced by ER stress. ATF6
is a type II ER transmembrane protein. Like IRE1 and
PERK, ATF6 binds to Bip and remains in an inactive state
in unstressed cells. In response to ER stress, the Bip/ATF6
complex is dissociated, resulting in the translocation of
ATF6 from ER membrane to Golgi apparatus. In Golgi
apparatus, ATF6 is cleaved by two proteases, serine protease
site-1 protease (S1P) and the metalloprotease site-2 protease
(S2P), to produce the active form of the transcription factor
[53–55]. The active ATF6 then moves to the nucleus and
activates the ER stress response element- (ERSE-) related
genes through binding their promoters [35]. ATF6 also
regulates other URP genes, such as XBP-1 and CHOP [56].
3.ERStress-AssociatedApoptosisin
Retina Cells
Previous studies suggest that the cell fate is dependent on
the balance between the extent/severity of ER stress and the
capacity of the ER to restore ER homeostasis through the
UPR [57–59] .T e m p o r a la n dm i l dE Rs t r e s sc a nb eo v e r c o m e
by the adaptive UPR, cell function maintained, and cells
survive. However, if the stress condition is prolonged and the
UPRfailstorestoretheERhomeostasis,theapoptoticsignal-
ing pathways will be initiated to remove the unhealthy cells.
Recently, several independent studies have provided ample4 Experimental Diabetes Research
evidence that ER stress is a potential cause of retinal vascular
andneuronalcelldeathindiseasessuchasglaucoma,diabetic
retinopathy and age-related macular degeneration [19, 60–
62]. ER stress has been observed in both cultured retinal cells
(vascular endothelial cells, pericytes, ganglion cells, Muller
cells, as well as RPE cells) and in the retina from animal
models of various diseases. Not surprisingly, the role of
ER stress has been extensively studied in the pathogenesis
of retinitis pigmentosa (RP) with mutations of various
retinal genes. In 2004, Rebello and associates reported that
expression of a mutant (R14W) of carbonic anhydrase IV, a
glycosylphosphatidylinositol-anchored protein that is highly
expressed in the choriocapillaris of the human eye, induced
u p r e g u l a t i o no fB i p ,P E R K ,a n dC H O P ,m a r k e r so fE Rs t r e s s
and the unfolded protein response, accompanied by apop-
tosis [63]. Similarly, enhanced ER stress was reported in RP
induced by the rhodopsin mutation P23H in Xenopus laevis
[64] and in rats [65, 66]. Further, stimulation of the UPR
in the retina or cultured retinal cells by preexposure to mild
ER stress protected photoreceptor neurons from oxidative
damage and cell death [67]. Moreover, overexpression of
Bip, an ER chaperone that facilitates protein folding and
reduces ER stress, attenuated retinal expression of CHOP
and the activation of apoptotic cascade and restored retinal
photoreceptor function in P23H rats [61]. In addition to
the genetic models of RP, ER stress was found remarkably
enhanced in retinal photoreceptors, coincident with pho-
toreceptor cell apoptosis, in a rodent model of light damage-
inducedretinaldegeneration[62].Theseﬁndingscollectively
support a causal role of ER stress in photoreceptor cell death
and retinal degeneration.
Another well-studied area for ER stress-related retinal
cell death is glaucoma. Increased ER stress markers were
observed in retinal ganglion cells in animal models of
ischemia-reperfusion and chronic glaucoma [68]. Cultured
retinalganglioncells(RGC-5,atransformedratganglioncell
line) treated with tunicamycin, a common ER stress inducer,
undergo apoptosis, accompanied by increased production
of ER stress-related proteins [19, 69]. In vivo, intravitreal
injection of tunicamycin resulted in loss of retinal ganglion
cells and reduced thickness of the inner retina. Moreover,
raisingIOPorintravitrealinjectionofN-methyl-D-aspartate
(NMDA), an excitotoxin that binds to the NMDA receptor
and induces neuron cell death, also increased the expression
of ER stress markers in retinal ganglion cells, amacrine
cells, and microglial cells [19]. Pharmaceutical induction of
Bipsigniﬁcantlyattenuatedtunicamycin-orNMDA-induced
apoptosis in retinal ganglion cells,suggestinga pivotal roleof
ER stress in retinal neuron cell death [69].
Loss of retinal vascular cells and apoptosis of retinal neu-
rons have been recognized as critical events and pathological
features of diabetic retinopathy [70–72]. Although currently
it remains to be investigated how ER stress signaling
pathwayscontribute to retinal cell death induced by diabetes,
recent studies by our group and others demonstrated that
ER stress was induced in early stage of diabetic retinopathy
and was implicated in retinal inﬂammation and vascular
damage [73–76]. In 2009, we reported increased ER stress
markers in the retina of diabetic Akita mice, in parallel with
elevated expression of inﬂammatory genes [73]. In cultured
retinal endothelial cells, ER stress was induced by hypoxia,
a potent stimulator of inﬂammation and angiogenesis, and
prevented by chemical chaperones. Moreover, we showed
that induction of ER stress in the retina was suﬃcient to
trigger an upregulation of inﬂammatory genes. Conversely,
inhibiting ER stress protected the retina and retinal endothe-
lial cells from inﬂammatory damage. In addition, activation
of the adaptive UPR by preconditioning with ER stress
also successfully prevented inﬂammatory damage to retinal
endothelial cells and vascular leakage induced by diabetic
stimulus [74]. These results suggest that ER stress is impli-
cated in retinal cell damage caused by diabetes.
4.SignalingPathways of
ERStress-AssociatedApoptosis
It is currently unclear how ER stress induces apoptosis in
various retinal cells. Generally, there are two major path-
ways for the initiation of apoptosis: extrinsic and intrinsic
pathways [77]. The extrinsic pathway is mediated by the
cell membrane death receptors. Activation of the death
receptor recruits adaptor molecules and activates caspase-
8 or caspase-10, which cleaves the downstream substrates,
that is, other caspases including caspase-3, resulting in
apoptosis [78]. The intrinsic pathway is closely related to
factorsanchoredonthemitochondria. Theinsertionofthese
proapoptotic proteins changes the mitochondrial membrane
permeability, resulting in the release of cytochrome c from
mitochondria into the cytosol. Then cytochrome c binds to
Apaf-1 and activates caspase-9 and then caspase-3, leading
to the execution of cell death. In addition, accumulating
evidence suggests that calcium release from the ER can also
initiate the cell death signals, either by directly activating
deathreceptorsorbyalteringthesensitivityofmitochondria.
Finally, these apoptotic pathways converge on caspase-3,
resulting in the cleavage of other proteases and leading
to apoptosis. In addition to caspase-dependent pathways,
caspase-independent pathway is also implicated in retina
apoptosis [79]. In the following sections, we discuss the
potential pathways that may play a role in ER stress-
associated apoptosis in various retinal diseases, such as
age-related macular degeneration, glaucoma, and diabetic
retinopathy (Figure 2).
4.1. CHOP: A Key Mediator of ER Stress-Induced Apoptosis.
CHOP, also named as growth-arrest and DNA-damage-
inducible gene 153 (GADD153), is a major stress-inducible
proapoptotic gene in ER stress-induced apoptosis [80]. All
three branches of the UPR regulate the activation of CHOP;
however, ATF4 is considered as the major inducer of CHOP
expression. CHOP is expressed at a very low level under
physiological conditions but its expression level signiﬁcantly
increases in the presence of severe or persistent ER stress.
Notably, the induction of CHOP well correlates with the
onset of ER stress-associated apoptosis [81, 82], silencing
CHOP expression protects cells against apoptosis induced by
prolonged ER stress [83]. As a transcription factor, CHOPExperimental Diabetes Research 5
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Figure 2: ER stress-associated apoptotic pathways in retinal diseases. A variety of pathogenic factors in chronic retinal degenerative diseases
(e.g., age-related macular degeneration, glaucomatous retinopathy and diabetic retinopathy), including aging, oxidative stress, hypoxia,
inﬂammatory factors, and hyperglycemia and others, can disturb ER function and compromise the adaptive UPR, resulting in persistent ER
stress in retinal cells. This leads to sustained activation of the ATF4/CHOP pathway and the IRE1/TRAF2/ASK/JNK pathway. Both JNK and
CHOP attenuate the function of the pro-survival factor Bcl-2, but enhances the activity of proapoptotic Bcl-2 proteins such as Bim, Bax,
and PUMA, resulting in mitochondrial dysfunction and cytochrome c release. In addition, caspase-12 is activated during ER stress, which
sequentially activates caspase-7 and/or caspase-3, leading to mitochondria-independent apoptosis.
hasbeenshowntoregulatenumerouspro-andantiapoptotic
genes, including Bcl-2, GADD34, and TRB3 [84]. CHOP
directly binds the promoter of TRB3 gene and upregulates
its expression [84], which in turn inhibits AKT activation,
resulting in apoptosis and cell death [85]. Intriguingly, TRB3
also regulates CHOP expression through negative feedback.
Overexpressing TRB3 inhibits the transcriptional induction
of CHOP while silencing TRB3 results in upregulation of
CHOP under both normal and stressed conditions [86].
Treatment with PBA, a chemical chaperone that attenuates
ERstress,restoresAKTphosphorylation,reducesCHOPand
TRB3 expression, and prevents apoptosis. These ﬁndings
indicate that CHOP is a key mediator of ER stress-induced
apoptosis and is tightly regulated by multiple factors, includ-
ingUPRcomponentssuchasATF4anditsdownstreamgenes
such as TRB3.
4.2. Mitochondria and the Bcl-2 Family. Recent evidence
suggests that mitochondrial dysfunction plays a role in ER
stress-induced apoptosis [20, 87]. ER stress, via the UPR,
also regulates a number of apoptosis-associated proteins
that localize on the mitochondrial membrane, notably the
members of the Bcl-2 family. These proteins are widely
held as the central coordinators of mitochondria-mediated
apoptotic pathways. The Bcl-2 family consists of antiapop-
totic members, such as Bcl-2 and Bcl-xL, and proapoptotic
proteins, such as Bax, Bak, and Bik [88]. The balance
between the anti- and proapoptotic proteins is important
for maintaining normal mitochondrial function as well
as cell survival. Cells overexpressing Bcl-2 or deﬁcient of
Bax and Bak are resistant to ER stress-induced apoptosis
[89]. Conversely, overexpressing Bax promotes cytochrome c
release and activates apoptotic enzymes, leading to cell6 Experimental Diabetes Research
death [90]. BH3-only proteins, such as Bim and Bax, are
proapoptoticmembersoftheBcl-2proteinfamily,playingan
essential role in the initiation of programmed cell death and
stress-induced apoptosis [91]. Recent studies show that both
the antiapoptotic gene Bcl-2 and the proapoptotic proteins,
for example, Bim and Bax, are regulated by CHOP during
ER stress [87, 92]. CHOP downregulates Bcl-2 expression
but upregulates Bim and promotes the translocation of Bax
into the mitochondria [93]. Another BH3-only protein, p53-
upregulated modulator of apoptosis (PUMA), is induced by
p53 during ER stress, and PUMA-deﬁcient cells are resistant
to ER stress-elicited apoptosis. These results imply an impor-
tant role of p53 and PUMA in ER stress-associated cell death
[94]. In addition to mediating ER stress-driven apoptosis,
the Bcl-2 family also regulates ER stress through physical
interaction with ER stress sensors and UPR components. For
example, both Bax and Bak have been reported to form a
protein complex with IRE1α, which is essential for IRE1α
activation [95]. Double knockout mice that lack Bax and
Bak exhibited decreased expression of XBP1, a substrate of
IRE1, and developed extensive tissue damage in the liver in
response to ER stress induced by tunicamycin [95]. Thus,
the mediators and pathways implicated in ER stress-related
apoptosisareverycomplex.Nevertheless,theinterdependent
regulation of Bcl-2 proteins and the UPR appears to be a key
event in the process of ﬁne tuning of pro- and antiapoptotic
system during ER stress.
4.3. Caspase-12: An ER-Resident Caspase. Caspase-12 is a
member of the inﬂammatory group of the caspase family,
localized to the ER. Moreover, it has been shown that
caspase-12 is speciﬁcally activated by ER stress, including
disruption of ER calcium homeostasis and accumulation
of excess proteins in ER, but not by membrane- or
mitochondrial-targeted apoptotic signals [96]. Mice deﬁ-
cient of caspase-12 are resistant to ER stress-induced apop-
tosis, suggesting that caspase-12 plays a critical role in
this process [96]. However, the human caspase-12 gene
has a single nucleotide polymorphism, which results in the
production of either a truncated caspase-12 protein or a full-
length protein with no enzymatic activity [97]. In human,
caspase-4, a member of caspase-1 subfamily that includes
caspase-12, was found localized to the ER membrane and
activated speciﬁcally by ER stress-inducers [98]. Cleavage
of caspase-4 was not aﬀected by overexpression of Bcl-2,
which prevents signal transduction on the mitochondria,
suggesting that caspase-4 is primarily activated in ER stress-
inducedapoptosis[98].Furthermore,areductionofcaspase-
4 expression by small interfering RNA decreased ER stress-
induced apoptosis in some cell lines, but not other ER
stress-independent apoptosis [98]. Although the role of
caspase-12(caspase-4inhuman)hasbeenwellestablished,it
remainsunclearhowcaspase-12isactivatedduringERstress.
Recent studies suggest that caspase-12 activation requires
the IRE1 signal [99]. Upon activation by ER stress, the
cytosolic domain of IRE1 recruits TNF receptor-associated
factor 2 (TRAF2), which interacts with caspase-12 and
induces the cleavage and activation of the enzyme [100]. In
turn, activated caspase-12 cleaves procaspase-9 into active
caspase-9, which further cleaves and activates caspase-3,
resulting in apoptosis [101]. In addition, caspase-12 can
also be activated by its downstream executioner caspase-
7, indicating a possible ampliﬁcation loop in the apoptotic
cascades though caspase-12 [102]. Notably, in caspase-12-
mediated apoptotic process, cytochrome c is not released
from mitochondria, which suggests that cytochrome c is not
involved in the caspase-12-dependent apoptosis [101].
4.4. The JNK Pathway in ER Stress-Mediated Apopto-
sis. The c-Jun N-terminal kinases/stress-activated protein
kinase (JNK/SAPK) pathway is one of three members of
the mitogen-activated protein kinase (MAPK) superfamily
which also includes the ERK and the p38 MAPKinases [103].
JNK is originally identiﬁed for speciﬁcally phosphorylating
the transcription factor c-jun in its N-terminal transacti-
vation domain [103]. There are three diﬀerent isoforms
of JNK (JNK1, 2, and 3). Among these isoforms, JNK1
and JNK2 are ubiquitously expressed while the expression
of JNK3 is tissue speciﬁc [104]. It has been reported that
JNK is activated by various stress factors and contributes to
apoptosis and cell death [105, 106]. Recent evidence suggests
that JNK activation is also involved in ER stress-initiated
apoptotic cascades [107]. For example, activation of IRE1
by ER stress recruits and activates tumor necrosis factor
receptor-associatedfactor2(TRAF2),whichfurtheractivates
JNK [99], resulting in caspase-12 activation and apoptosis
[100]. IL-1β, a proinﬂammatory cytokine, stimulates JNK
activation and enhances ER stress in pancreatic epithelial
cells [108]. Pretreatment with JNK inhibitor abrogates IL-
1β-inducedERstress,indicatedbyphosphorylationofeIF2α,
and increased expression of CHOP, GADD34, ATF4, and
spliced XBP-1 while inhibition of ER stress does not aﬀect
JNK activation by IL-1β [108]. This suggests that JNK acti-
vation is required for IL-1β-induced ER stress. In addition,
recent studies demonstrate that inhibiting JNK resulted in
reduced ATF4 expression during osteoblast diﬀerentiation.
JNK inhibition also alleviated Bcl-2 antagonist-induced ER
stress in a lymphoma cell line [109, 110]. These ﬁndings
collectively indicate a pivotal role of JNK in induction of ER
stressandinmediatingERstress-inducedapoptosis,whichis
yet to be studied in retinal cell apoptosis and retinal diseases.
4.5. Fas-FasL-Induced Apoptosis. The Fas death receptor
belongs to the TNF receptor superfamily and is known
as important inducer of apoptosis. Fas, through binding
to its ligand FasL, recruits and activates the zymogen
(precursor) form of cysteine protease caspases, particularly
procaspase-8 and -10, which in turn activate caspase-3 and
the downstream apoptotic cascades [111, 112]. Previous
studies reported that Fas-FasL system is activated in diabetic
retinopathy and is implicated in retinal vascular cell death
in diabetic animals [113]. Treatment of retinal endothelial
cells with neutrophils isolated from patients with diabetic
retinopathy induced adhesion of neutrophils to endothelium
and caused endothelial apoptosis [114]. Blockade of the
Fas-FasL interaction prevented retinal endothelial apoptosis
[114]. In an in vivo study, inhibiting FasL potently reducedExperimental Diabetes Research 7
retinal vascular endothelial cell injury, apoptosis, and
blood-retinal barrier breakdown in diabetic animals [115].
Increased immunoreactivity of Fas/FasL and Fas-associated
death domain (FADD) was observed in retinal glial cells
and ganglion cells in rats with experimental glaucoma [116].
These ﬁndings suggest an important role of Fas-FasL system
in retinal cell death. While it is widely held that binding and
interaction of Fas and FasL are important for activation of
the Fas signaling, recent studies suggest that Fas can also
be regulated independently of FasL. Timmins and associates
reported that Fas expression was induced by ER stress
throughapathwayinvolvingcalcium/calmodulin-dependent
protein kinase IIgamma (CaMKIIgamma) and JNK [117].
In addition, activation of CaMKII by ER stress also acti-
vated STAT1, a proapoptotic signal transducer, and induced
mitochondrial-dependent apoptosis, including release of
mitochondrial cytochrome c and loss of mitochondrial
membrane potential [117]. It was proposed that prolonged
CHOP expression leads to the release of ER calcium stores,
which increases cytosolic calcium concentration, resulting in
CaMKII activation and apoptotsis. The role of CaMKII in
retinal cell apoptosis remains to be elucidated.
5.Perspectives
Emerging evidence suggests that ER stress plays a pivotal
role in retinal apoptosis and cell death. Studies in other
ﬁelds have identiﬁed a number of signaling pathways that are
implicated in ER stress-mediated apoptotic process. These
include CHOP induction, caspase-12 activation, mitochon-
dria dysfunction, JNK activation, Fas-FasL system and the
STAT1 pathway. Blocking each of these pathways reduces
or prevents ER stress-induced apoptosis to a certain extent;
however, induction of an individual proapoptotic pathway
maynotbesuﬃcienttoinduceapoptosis[117].Thissuggests
that prolonged ER stress may activate multiple subthresh-
old proapoptotic pathways, and these pathways interact
and regulate each other to execute apoptosis. In addition,
prolonged ER stress may also suppress the compensatory
cell survival pathways induced by the UPR, such as the
IFN-β and Akt-p38α pathways [117]. Recently, we demon-
strated that enhancing the endogenous adaptive UPR system
by preconditioning retinal cells with mild ER stress was
able to reduce vascular inﬂammation and retinal vascular
leakage [74]. Moreover, inducing molecular chaperones,
for example, heat shock protein 90 (Hsp90), by antibi-
otics [118] prevents protein aggregation and that protects
photoreceptors against retinal degeneration in a murine
model of autosomal dominant retinitis pigmentosa (ADRP)
[119]. In addition, overexpressing Bip/Bip in retinal pho-
toreceptors alleviated ER stress, reduced CHOP expression,
and mitigated photoreceptor apoptosis in P23H rhodopsin
transgenic rats [61]. These ﬁndings support an essential role
of the adaptive URP system and the URP-activated survival
pathways in protecting retinal cells against apoptosis and
cell death. Therefore, identifying the key proapoptotic and
antiapoptotic pathways implicated in ER stress-associated
apoptosis and addressing how these pathways are involved
in diﬀerent pathological conditions of retinal cells may oﬀer
the opportunity for developing new drugs to treat retinal
diseases.
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